Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01744132 · ClinicalTrials.gov registry record · NA

Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes

A NA study, sponsored by Wills Eye.

Completed
Registry status
NA
Development phase
3,000
Enrollment target

NCT01744132 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 3,000 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01744132, a NA study, has completed, sponsored by Wills Eye.

COMPLETED
Registry status
NA
Development phase
3,000 participants
Enrollment target

Study Summary

The goal of this project is to implement a Collaborative Translational Research Center (TRC) Network Study which aims to assure optimal two-way communication between ophthalmologists and their patients' primary care physicians (PCP). The Collaborative TRC Network Study will have 2 objectives: * To design and develop common research protocols to develop a 4-year retrospective database (2007-2010) that compiles electronic billing and medical chart information that can be used to study individual-level, clinical-level and system-level factors that impact access to and quality of vision care; * To evaluate adherence to dilated fundus exams (DFEs) follow-up as the primary measureable quality indicator, and its relationship to the patients' demographics, ethnicity, socioeconomic status (SES), severity of diabetic retinopathy (DR), other ocular and medical co-morbidities, presence of HA1C, and primary care provider (PCP) communication. By enhancing communication and strengthening the clinical information exchanged between PCPs and eye care professionals, this Collaborative TRC Network study will help to overcome barriers to obtaining ongoing DFEs and reduce disparities in vision care utilization.

Interventions

  • BEHAVIORAL Aim 3: Contract

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2012-10
Est. Completion 2016-10
Phase NA

Sponsor

Wills Eye

59 total trials

What the Registry Record Tells You About NCT01744132

The ClinicalTrials.gov registry entry for NCT01744132 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Aim 3: Contract is the first listed.

NCT01744132 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01744132 about?

NCT01744132 is a clinical study titled "Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes". The goal of this project is to implement a Collaborative Translational Research Center (TRC) Network Study which aims to assure optimal two-way communication between ophthalmologists and their patients' primary care physicians (PCP). The Collaborative TRC Network Study will have 2 objectives: * To ...

What is the current status of trial NCT01744132?

This trial is currently completed. It is a NA study. The enrollment target is 3,000 participants. The study started on 2012-10. Estimated completion is 2016-10.

What interventions are being tested in trial NCT01744132?

The interventions under investigation include: Aim 3: Contract (BEHAVIORAL).

Who is sponsoring clinical trial NCT01744132?

This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.